March is Kidney Cancer Awareness Month

Study finds 4% of patients with metastatic renal cell carcinoma developed asymptomatic brain metastases, correlating to poorer outcomes.

The kinase inhibitor delayed disease progression by 27% for people who had tried at least two prior therapies.

First-line Lenvima plus Keytruda yields better overall survival for patients with metastatic kidney cancer.

The immunotherapy combination slowed disease progression and reduced the risk of death by 40%.

Metastatic kidney cancer patients with greater microbial diversity had better outcomes with immunotherapy.

Through her sculptures, Shelley Kerr describes the battle, journey and gratitude of living with stage IV bladder cancer.

These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.

A survey of people with kidney cancer reveals that they fear both COVID-19 and cancer progression equally.